Send E-mail
  • Green Cross Cell, ToolGen to collaborate on cancer therapy
    Green Cross Cell, ToolGen to collaborate on cancer therapy
     Cell therapy developer Green Cross Cell and biotechnology firm ToolGen on Aug. 22 signed a memorandum of understanding on collaborating in developing immune therapy for cancer. The two companies plan to apply ToolGen’s DNA scissor technology to Green Cross Cell’s anti-cancer immune therapy. The companies hope to amplify T-cells’ ability to attack cancer cells. By Choi He-suk (cheesuk@heraldcorp.com)
From
Send to
Close Send

Green Cross Cell, ToolGen to collaborate on cancer therapy

Aug. 22, 2016 - 16:21 By 최희석
[THE INVESTOR] Cell therapy developer Green Cross Cell and biotechnology firm ToolGen on Aug. 22 signed a memorandum of understanding on collaborating in developing immune therapy for cancer.

The two companies plan to apply ToolGen’s DNA scissor technology to Green Cross Cell’s anti-cancer immune therapy.

The companies hope to amplify T-cells’ ability to attack cancer cells.

By Choi He-suk (cheesuk@heraldcorp.com)
Most Popular